FDA NDC
alogliptin and metformin hydrochloride
This name is from the loaded FDA file.
Source: FDA NDC Directory, live from openFDA. Publisher page
- NDC
- 45802-169
- Proprietary name
- alogliptin and metformin hydrochloride
- Nonproprietary name
- alogliptin and metformin hydrochloride
- Labeler
- Padagis Israel Pharmaceuticals Ltd
- Dosage form
- TABLET, FILM COATED
- Strength
- 12.5 mg/1
Run it in Rivvi
Which 2027 plans near you dropped or restricted alogliptin and metformin hydrochloride?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan, from the CMS Part D files.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.